Breast cancer is the most commonly diagnosed invasive cancer among women both
globally and within the United States and the number one cause of cancer-related deaths …

Purpose In this review, the current knowledge on anti-Müllerian hormone (AMH) is
presented, concerning its value in disease and IVF treatment as well as in terms of its …

Among women, breast cancer (BC) is not only the most common cancer worldwide but also
the leading cause of cancer death. Only 5–10% of breast cancer cases are attributed to …

Background Models that accurately predict risk of breast cancer are needed to help younger
women make decisions about when to begin screening. Premenopausal concentrations of …

STUDY QUESTION Can additional genetic variants for circulating anti-Müllerian hormone
(AMH) levels be identified through a genome-wide association study (GWAS) meta-analysis …

Polycystic ovary syndrome (PCOS) risk factors overlap with breast cancer, and the hormonal
profile may be implicated in breast cancer pathogenesis. This study aims to report a …

Anti-Müllerian hormone (AMH) is required for sexual differentiation in the fetus, and in adult
females AMH is produced by growing ovarian follicles. Consequently, AMH levels are …

Polycystic ovary syndrome (PCOS) is an endocrine disorder characterized by ovarian cysts,
high androgen levels, and irregular menstruation. The causality between PCOS and breast …

Polycystic ovary syndrome is a low-grade inflammatory state with increased serum levels of
TNF-α. The present study has compared the inflammatory responses to breast cancer cell …

Context Breast cancer is the most common malignancy in women. Noninvasive biomarkers
are needed for its early diagnosis and/or prognosis. Objective The aim of this case-control …